SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001654954-21-003303
Filing Date
2021-03-25
Accepted
2021-03-25 17:07:38
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-3 ndra_s3.htm S-3 344429
2 FORM OF INDENTURE endra_ex49.htm EX-4.9 591080
3 OPINION OF K&L GATES LLP AS TO LEGALITY OF SECURITIES BEING REGISTERED ndra_ex51.htm EX-5.1 35762
4 CONSENT OF RBSM LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ndra_ex231.htm EX-23.1 4265
5 IMAGE ndra_ex51000.jpg GRAPHIC 2302
6 IMAGE ndra_s3000.jpg GRAPHIC 12779
7 IMAGE ndra_s3001.jpg GRAPHIC 12675
  Complete submission text file 0001654954-21-003303.txt   1015258
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-254711 | Film No.: 21773234
SIC: 3845 Electromedical & Electrotherapeutic Apparatus